文献速递心境障碍

裸盖菇素增强重度抑郁症患者的情感共情

Psilocybin increases emotional empathy in patients with major depression.
PubMed 文献 · Mol Psychiatry · 2024-12-18

裸盖菇素组在给药后至少两周内显式情感共情显著改善,且由对正性刺激的共情增加驱动;作者认为需进一步研究社会认知与临床疗效的交互作用。

要点

  • 裸盖菇素组显式情感共情较安慰剂组显著改善,持续至少两周。
  • 改善由对正性刺激的共情增加驱动。
  • 作者指出需进一步研究社会认知与临床疗效的交互作用。

核心结论

  • 裸盖菇素辅助治疗可使抑郁症患者显式情感共情显著改善,并持续至少两周,改善由对正性刺激的共情增加驱动。

研究设计与样本

  • 采用多维度共情测试(Multifaceted Empathy Test)在基线及给药后2天、1周、2周评估共情,比较两种治疗条件间的共情变化。

主要发现

  • 接受裸盖菇素的患者较安慰剂组在显式情感共情上显示显著改善,且由对正性刺激的共情增加驱动,持续至少两周。

局限性

  • 作者指出需进一步研究社会认知与临床疗效之间的交互作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Empathy plays a crucial role in interpersonal relationships and mental health. It is decreased in a variety of psychiatric disorders including major depression. Psilocybin, a promising candidate for treating depression, has been shown to acutely increase emotional empathy in healthy volunteers. However, no study has investigated this effect and its relevance for symptom improvement in a clinical population. This study examines the enduring effects of psilocybin-assisted therapy on empathy in depressed patients using a randomized, placebo-controlled design. Fifty-one depressed patients were randomly assigned to receive a single dose of psilocybin (0215 mg/kg body weight) or a placebo embedded in a 4-week psychological support intervention. Empathy was measured using the Multifaceted Empathy Test at baseline and 2 days, 1 week, and 2 weeks after substance administration. Changes in empathy were compared between treatment conditions. Patients who received psilocybin showed significant improvements in explicit emotional empathy driven by an increase in empathy towards positive stimuli compared to the placebo group for at least two weeks. This study highlights the potential of psychedelics to enhance social cognition in individuals living with depression and contributes to a better understanding of the psychological mechanisms of action of psychedelics. Further studies are necessary to investigate the interaction between social cognition and clinical efficacy.The trial is registered on clinicaltrials.gov (Identifier: NCT03715127) and KOFAM (Identifier: SNCTP000003139).

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Jungwirth J, von Rotz R, Dziobek I, et al. Psilocybin increases emotional empathy in patients with major depression. Mol Psychiatry. 2024. PMID: 39695323. doi:10.1038/s41380-024-02875-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。